Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 833

1.
2.

The challenges of delivering genetically modified crops with nutritional enhancement traits.

Napier JA, Haslam RP, Tsalavouta M, Sayanova O.

Nat Plants. 2019 Jun;5(6):563-567. doi: 10.1038/s41477-019-0430-z. Epub 2019 Jun 3. Review.

PMID:
31160704
3.

Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases.

Serini S, Cassano R, Trombino S, Calviello G.

Int J Nanomedicine. 2019 Apr 23;14:2809-2828. doi: 10.2147/IJN.S197499. eCollection 2019. Review.

4.

Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

Darwesh AM, Sosnowski DK, Lee TY, Keshavarz-Bahaghighat H, Seubert JM.

Chem Biol Interact. 2019 Aug 1;308:20-44. doi: 10.1016/j.cbi.2019.04.037. Epub 2019 May 5. Review.

5.

The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.

Nelson JR, Raskin S.

Postgrad Med. 2019 May;131(4):268-277. doi: 10.1080/00325481.2019.1607414. Epub 2019 May 7. Review.

PMID:
31063407
6.

Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia.

Doggrell SA.

Expert Opin Pharmacother. 2019 Jul;20(10):1221-1225. doi: 10.1080/14656566.2019.1609942. Epub 2019 Apr 30. Review.

PMID:
31038369
7.

Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome.

Amatruda M, Ippolito G, Vizzuso S, Vizzari G, Banderali G, Verduci E.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2118. doi: 10.3390/ijms20092118. Review.

8.

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation.

Yang J, Fernández-Galilea M, Martínez-Fernández L, González-Muniesa P, Pérez-Chávez A, Martínez JA, Moreno-Aliaga MJ.

Nutrients. 2019 Apr 18;11(4). pii: E872. doi: 10.3390/nu11040872.

9.

Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials.

Kawashima H.

Lipids Health Dis. 2019 Apr 16;18(1):101. doi: 10.1186/s12944-019-1039-y. Review.

10.

The Role of Docosahexaenoic Acid (DHA) on Cognitive Functions in Psychiatric Disorders.

Ciappolino V, Mazzocchi A, Botturi A, Turolo S, Delvecchio G, Agostoni C, Brambilla P.

Nutrients. 2019 Apr 2;11(4). pii: E769. doi: 10.3390/nu11040769.

11.

Fish Oil Based Lipid Emulsions for the Treatment of Intestinal Failure Associated Liver Disease: Nothing Fishy About it!

Bolia R, Srivastava A.

Indian J Pediatr. 2019 Jun;86(6):494-495. doi: 10.1007/s12098-019-02944-1. Epub 2019 Apr 10. Review. No abstract available.

PMID:
30972700
12.

Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies.

Zhu Y, Bo Y, Liu Y.

Lipids Health Dis. 2019 Apr 6;18(1):91. doi: 10.1186/s12944-019-1035-2. Review.

13.

Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption.

Nguyen QV, Malau-Aduli BS, Cavalieri J, Malau-Aduli AEO, Nichols PD.

Nutrients. 2019 Mar 29;11(4). pii: E743. doi: 10.3390/nu11040743. Review.

14.

Omega-3 and ranibizumab for age-related macular degeneration: A systematic review protocol.

Meng Y, Liu HW, Sun P, Zhou PP, Wang JJ.

Medicine (Baltimore). 2019 Mar;98(13):e14516. doi: 10.1097/MD.0000000000014516.

15.

Management of dyslipidaemias in the elderly population-A narrative review.

Anagnostis P, Vaitsi K, Veneti S, Georgiou T, Paschou SA, Lambrinoudaki I, Goulis DG.

Maturitas. 2019 Jun;124:93-99. doi: 10.1016/j.maturitas.2019.03.011. Epub 2019 Mar 19. Review.

PMID:
30910278
16.

Advances in n-3 polyunsaturated fatty acid nutrition.

Li D, Wahlqvist ML, Sinclair AJ.

Asia Pac J Clin Nutr. 2019;28(1):1-5. doi: 10.6133/apjcn.201903_28(1).0001. Review.

17.

Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?

Ornoy A, Weinstein-Fudim L, Ergaz Z.

Int J Mol Sci. 2019 Mar 1;20(5). pii: E1074. doi: 10.3390/ijms20051074. Review.

18.

Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.

Sima C, Paster B, Van Dyke TE.

Crit Rev Immunol. 2018;38(5):343-365. doi: 10.1615/CritRevImmunol.2018026750. Review.

19.

Protective Effect of Omega-3 Fatty Acids in Fish Consumption Against Breast Cancer in Asian Patients: A Meta-Analysis

Nindrea RD, Aryandono T, Lazuardi L, Dwiprahasto I.

Asian Pac J Cancer Prev. 2019 Feb 26;20(2):327-332. Review.

20.

Effect of ω-3 polyunsaturated fatty acids on liver function and inflammatory reaction in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized control trials.

Zhang C, Lin J, Li F, Li Y, Jiang B, Bai H, Zhang J.

Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):375-384. doi: 10.1080/17474124.2019.1578648. Epub 2019 Feb 22.

PMID:
30791756

Supplemental Content

Loading ...
Support Center